Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Brunner

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Experimental Neurology|May 6, 2008
Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophyBassem F El-Khodor, Nicole Edgar, Angela Chen, et al.
Psychopharmacology|July 24, 2008
Pharmacological manipulations of interval timing using the peak procedure in male C3H miceFuat Balci, Elliot A Ludvig, Jacqueline M Gibson, et al.
Microbiome|January 25, 2021
Microbiome dynamics during the HI-SEAS IV mission, and implications for future crewed missions beyond EarthAlexander Mahnert, Cyprien Verseux, Petra Schwendner, et al.
Journal of Medicinal Chemistry|June 6, 2013
Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part IIHan-Kun Zhang, Li-Fang Yu, J Brek Eaton, et al.
Journal of Cell Science|November 1, 2015
Plectin reinforces vascular integrity by mediating crosstalk between the vimentin and the actin networksSelma Osmanagic-Myers, Stefanie Rus, Michael Wolfram, et al.
Frontiers in Behavioral Neuroscience|January 22, 2016
Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HDPaul C P Curtin, Andrew M Farrar, Stephen Oakeshott, et al.
Biochemical and Biophysical Research Communications|July 22, 2014
Characterization of rat serum amyloid A4 (SAA4): a novel member of the SAA superfamilyChristine Rossmann, Christian Windpassinger, Daniela Brunner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disordersKristine Roy, Joshua C Murtie, Bassem F El-Khodor, et al.
Plos One|March 27, 2010
Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineLiliana B Menalled, Monica Patry, Natalie Ragland, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Experimental Neurology|May 6, 2008
Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophyBassem F El-Khodor, Nicole Edgar, Angela Chen, et al.
Psychopharmacology|July 24, 2008
Pharmacological manipulations of interval timing using the peak procedure in male C3H miceFuat Balci, Elliot A Ludvig, Jacqueline M Gibson, et al.
Microbiome|January 25, 2021
Microbiome dynamics during the HI-SEAS IV mission, and implications for future crewed missions beyond EarthAlexander Mahnert, Cyprien Verseux, Petra Schwendner, et al.
Journal of Medicinal Chemistry|June 6, 2013
Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part IIHan-Kun Zhang, Li-Fang Yu, J Brek Eaton, et al.
Journal of Cell Science|November 1, 2015
Plectin reinforces vascular integrity by mediating crosstalk between the vimentin and the actin networksSelma Osmanagic-Myers, Stefanie Rus, Michael Wolfram, et al.
Frontiers in Behavioral Neuroscience|January 22, 2016
Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HDPaul C P Curtin, Andrew M Farrar, Stephen Oakeshott, et al.
Biochemical and Biophysical Research Communications|July 22, 2014
Characterization of rat serum amyloid A4 (SAA4): a novel member of the SAA superfamilyChristine Rossmann, Christian Windpassinger, Daniela Brunner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disordersKristine Roy, Joshua C Murtie, Bassem F El-Khodor, et al.
Plos One|March 27, 2010
Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineLiliana B Menalled, Monica Patry, Natalie Ragland, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.
Pageof 4